TABLE 1.
Group | N | Age mean (SD) | Males (%) | Female (%) | HY mean (SD) | MDS‐UPDRS III total score mean (SD) | Months from diagnosis (SD) | LEDD mean (SD) | MDS‐UPDRS III mean scores for the right upper limb (SD) | MDS‐UPDRS III mean scores for the right lower limb (SD) | MDS‐UPDRS III mean scores for the left upper limb (SD) | MDS‐UPDRS III mean scores for the left lower limb (SD) | % of PD patients with right upper limb MDS‐UPDRS III score >0 | % of PD patients with right lower limb MDS‐UPDRS III score >0 | % of PD patients with left upper limb MDS‐UPDRS III score >0 | % of PD patients with left lower limb MDS‐UPDRS III score >0 | % of PD patients with MDS‐UPDRS III score >0 for right limbs | % of PD patients with MDS‐UPDRS III score >0 for left limbs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Healthy controls | 50 | 65.5 (2.7) | 39 (78.0) | 11 (22%) | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
PD patients | 64 | 66.6 (8.8) | 40 (62.5) | 24 (37.5) | 1.86 (0.73) | 15.7 (8.88) | 20.8 (17.21) | 308.57 (232.6) | 4.3 (2.13) | 2.2 (0.97) | 3.9 (1.95) | 2.4 (1.04) | 84.4 | 71.9 | 81.2 | 65.6 | 86.9 | 82.8 |
Abbreviations: HY, Hoehn and Yahr scale; LEDD, levodopa equivalent daily dose; MDS‐UPDRS, Movement disorders society—Unified Parkinson's Disease Rating Scale; PD, Parkinson's disease; SD, standard deviation.